Initial Weight Loss, Anthropometric Parameters, and Proinflammatory Transcript Levels in Patients with Class I Obesity.

Beata Jabłonowska-Lietz, Grażyna Nowicka, Marta Włodarczyk, Sławomir Rejowski, Maria Stasiowska, Małgorzata Wrzosek

Open access · goldAbstract read

In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 82% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Beata Jabłonowska-LietzMedical Center, National Institute of Public Health NIH-National Research Institute, 24 Chocimska St., 00-791 Warsaw, Poland.

Grażyna NowickaDepartment of Biochemistry and Pharmacogenomics, Center for Preclinical Research, Medical University of Warsaw, 1 Banacha St., 02-097 Warsaw, Poland.ORCID 0000-0001-9556-6813

Marta WłodarczykDepartment of Biochemistry and Pharmacogenomics, Center for Preclinical Research, Medical University of Warsaw, 1 Banacha St., 02-097 Warsaw, Poland.ORCID 0000-0003-1545-2547

Sławomir RejowskiLiver and Internal Medicine Unit, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, 1A Banacha St., 02-097 Warsaw, Poland.

Maria StasiowskaDepartment of Anaesthesia and Intensive Care, University College London Hospital, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.

Małgorzata WrzosekDepartment of Biochemistry and Pharmacogenomics, Center for Preclinical Research, Medical University of Warsaw, 1 Banacha St., 02-097 Warsaw, Poland.ORCID 0000-0002-9820-3871

Medical University of Warsaw · PLNarodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy · PLRoyal London Hospital · GB

Funding

National Science Center N2011/01/N/NZ7/04559

6 · The paper itself

Abstract

Research into early predictors of effective weight loss could help determine more effective therapeutic interventions. In this study, 106 subjects with class I obesity, genotyped with the fat mass and obesity-associated (

Indexed as

BIAFTO rs9930506 polymorphismHOMA-IRproinflammatory gene expressionsubcutaneous adipose tissueweight loss predictors

Identifiers

PMID37626800

DOI10.3390/biomedicines11082304

PMCPMC10452077

OpenAlexW4386030626

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.